Herceptin


Also found in: Medical, Wikipedia.
Related to Herceptin: HER2

Her·cep·tin

 (hər-sĕp′tn)
A trademark for the drug trastuzumab.

Herceptin

(hərˈsɛptɪn)
n
(Pharmacology) trademark a monoclonal antibody that inhibits the protein that can fuel tumour growth, used in the treatment of breast cancer
References in periodicals archive ?
Herceptin alone is approved for the treatment of HER2-positive mBC in patients who have received one or more chemotherapy regimens for metastatic disease.
Decision Resources' new special report entitled Gastric Cancer in China: Physician and Payer Perspectives on Optimizing Market Access for Premium-Priced Treatment also finds that substantial barriers currently exist for gastric cancer patients to access Herceptin in China, primarily due to lack of reimbursement and the high out-of-pocket expenses.
A new injection of the drug Herceptin, given just beneath the skin, can be completed in two to five minutes, compared to a time-consuming 30 to 90 minute intravenous infusion.
Roche today announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy significantly extended the lives (overall survival) of people with previously untreated HER2-positive metastatic breast cancer (mBC), compared to Herceptin, chemotherapy and placebo.
Adding Afinitor to Herceptin, the main treatment for HER2-positive metastatic breast cancer, helps some women with disease that has been resistant to previous Herceptin-based therapies, it was found.
THE woman who fought for Herceptin for Welsh breast cancer patients has spoken of her debt of gratitude to the drug a decade on from its UK launch.
The decision by Pharmac earlier last month not to fund a 12-month course of the breast cancer drug Herceptin has drawn a mixed response from women's groups and the wider community.
Roche Holding AG, the world's biggest maker of tumor drugs, said a late- stage study showed its Herceptin medicine helped slow the spread of breast cancer when combined with its chemotherapy treatment Xeloda.
The new research, presented at the annual meeting of the American Society for Clinical Oncology in Chicago, suggests women on Herceptin benefit from continuing with the drug after their disease stops responding to traditional chemotherapy.
The phase III study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting investigated the use of neoadjuvant (treatment given prior to surgery) Herceptin in combination with chemotherapy in patients with locally advanced HER2-positive breast cancer, a particularly aggressive form of the disease.
The Food and Drug Administration has granted expanded approval to the drug Herceptin.
Mother-of-two Joanne Smith is finally keeping her cancer at bay with lifesaving wonder-drug Herceptin.